The XRCC1 -77T→C variant: Haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage

Carcinogenesis

Volumn 27, Issue 12, 2006, Pages 2469-2474

  Brem, Reto ^a   Cox, David G ^b   Chapot, Brigitte ^a   Moullan, Norman ^a   Romestaing, Pascale ^c   Gérard, Jean Pierre ^d   Pisani, Paola ^a   Hall, Janet ^a,e  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d CENTRE ANTOINE LACASSAGNE   (France)

^e INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; X RAY REPAIR CROSS COMPLEMENTING 1 PROTEIN; DNA BINDING PROTEIN; X RAY REPAIR CROSS COMPLEMENTING PROTEIN 1; X-RAY REPAIR CROSS COMPLEMENTING PROTEIN 1;

5' UNTRANSLATED REGION; ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; HUMAN CELL; IONIZING RADIATION; MAJOR CLINICAL STUDY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; RADIOSENSITIVITY; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; BREAST TUMOR; CELL CYCLE; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY;

BREAST NEOPLASMS; CELL CYCLE; CELL SURVIVAL; DNA DAMAGE; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; VARIATION (GENETICS);

EID: 33845352303     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl114     Document Type: Article

References (35)

1. Brem,R. and Hall,J. (2005) XRCC1 is required for DNA single-strand break repair in human cells. Nucleic Acids Res., 33, 2512-2520.
2. Carrano,A.V., Minkler,J.L., Dillehay,L.E. and Thompson,L.H. (1986) Incorporated bromodeoxyuridine enhances the sister-chromatid exchange and chromosomal aberration frequencies in an EMS-sensitive Chinese hamster cell line. Mutat. Res., 162, 233-239.
3. Dominguez,I., Daza,P., Natarajan,A.T. and Cortes,F. (1998) A high yield of translocations parallels the high yield of sister-chromatid exchanges in the CHO mutant EM9. Mutat. Res., 398, 67-73.
4. Thompson,L.H., Brookman,K.W., Dillehay,L.E., Mooney,C.L. and Carrano,A.V. (1982) Hypersensitivity to mutation and sister-chromatid exchange induction in CHO cell mutants defective in incising DNA containing UV lesions. Somatic Cell Genet., 8, 759-773.
5. Trucco,C., Oliver,F.J., de Murcia,G. and Menissier-de Murcia,J. (1998) DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines. Nucleic Acids Res., 26, 2644-2649.
6. Tebbs,R.S., Flannery,M.L., Meneses,J.J., Hartmann,A., Tucker,J.D., Thompson,L.H., Cleaver,J.E. and Pedersen,R.A. (1999) Requirement for the XRCC1 DNA base excision repair gene during early mouse development. Dev. Biol., 208, 513-529.
7. Thompson,L.H., Brookman,K.W., Dillehay,L.E., Carrano,A.V., Mazrimas,J.A., Mooney,C.L. and Minkler,J.L. (1982) A CHO-cell strain having hypersensitivity to mutagens, a defect in DNA strand-break repair, and an extraordinary baseline frequency of sister-chromatid exchange. Mutat. Res., 95, 427-440.
8. Thompson,L.H., Brookman,K.W., Jones,N.J., Allen,S.A. and Carrano,A.V. (1990) Molecular cloning of the human XRCC1 gene, which corrects defective DNA strand-break repair and sister-chromatid exchange. Mol. Cell. Biol., 10, 6160-6171.
9. Luo,H., Chan,D.W., Yang,T. et al. (2004) A new XRCC1-containing complex and its role in cellular survival of methyl methanesulfonate treatment. Mol. Cell. Biol., 24, 8356-8365.
10. Hu,Z., Ma,H., Chen,F., Wei,Q. and Shen,H. (2005) XRCC1 polymorphisms and cancer risk: A meta-analysis of 38 case-control studies. Cancer Epidemiol. Biomarkers Prev., 14, 1810-1818.
11. Hung,R.J., Hall,J., Brennan,P. and Boffetta,P. (2005) Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review. Am. J. Epidemiol., 162, 925-942.
12. Chang-Claude,J., Popanda,O., Tan,X.L. et al. (2005) Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin. Cancer Res., 11, 4802-4809.
13. de Las Penas,R., Sanchez-Ronco,M., Alberola,V. et al. (2006) Polymorphisms in DNA repair genes modulate survival in cisplatin/ gemcitabine-treated non-small-cell lung cancer patients. Ann. Oncol., 17, 668-675.
14. Gurubhagavatula,S., Liu,G., Park,S., Zhou,W., Su,L., Wain,J.C., Lynch,T.J., Neuberg,D.S. and Christiani,D.C. (2004) XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy. J. Clin. Oncol., 22, 2594-2601.
15. Nagasubramanian,R., Innocenti,F. and Ratain,M.J. (2003) Pharmacogenetics in cancer treatment. Annu. Rev. Med., 54, 437-452.
16. Fernet,M. and Hall,J. (2004) Genetic biomarkers of therapeutic radiation sensitivity. DNA Repair (Amst.), 3, 1237-1243.
17. Hao,B., Wang,H., Zhou,K. et al. (2004) Identification of genetic variants in base excision repair pathway and their associations with risk of esophageal squamous cell carcinoma. Cancer Res., 64, 4378-4384.
18. Hu,Z., Ma,H., Lu,D. et al. (2005) A promoter polymorphism (-77T→C) of DNA repair gene XRCC1 is associated with risk of lung cancer in relation to tobacco smoking. Pharmacogenet. Genomics, 15, 457-463.
19. Moullan,N., Cox,D.G., Angele,S., Romestaing,P., Gerard,J.P. and Hall,J. (2003) Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol. Biomarkers Prev., 12, 1168-1174.
20. Angele,S., Romestaing,P., Moullan,N. et al. (2003) ATM haplotypes and cellular response to DNA damage: Association with breast cancer risk and clinical radiosensitivity. Cancer Res., 63, 8717-8725.
21. Cox,J.D., Stetz,J. and Pajak,T.F. (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int. J. Radiat. Oncol. Biol. Phys., 31, 1341-1346.
22. Gilad,S., Chessa,L., Khosravi,R., Russell,P., Galanty,Y., Piane,M., Gatti,R.A., Jorgensen,T.J., Shiloh,Y. and Bar-Shira,A. (1998) Genotype-phenotype relationships in ataxia-telangiectasia and variants. Am. J. Hum. Genet., 62, 551-561.
23. Renno,T., Hahne,M. and MacDonald,H.R. (1995) Proliferation is a prerequisite for bacterial superantigen-induced T cell apoptosis in vivo. J. Exp. Med., 181, 2283-2287.
24. Kraft,P., Cox,D.G., Paynter,R.A., Hunter,D. and De Vivo,I. (2005) Accounting for haplotype uncertainty in matched association studies: A comparison of simple and flexible techniques. Genet. Epidemiol., 28, 261-272.
25. Zaykin,D.V., Westfall,P.H., Young,S.S., Karnoub,M.A., Wagner,M.J. and Ehm,M.G. (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum. Hered., 53, 79-91.
26. Pachkowski,B.F., Winkel,S., Kubota,Y., Swenberg,J.A., Millikan,R.C. and Nakamura,J. (2006) XRCC1 genotype and breast cancer: Functional studies and epidemiologic data show interactions between XRCC1 codon 280 His and smoking. Cancer Res., 66, 2860-2868.
27. Chacko,P., Rajan,B., Joseph,T., Mathew,B.S. and Pillai,M.R. (2005) Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res. Treat., 89, 15-21.
28. Metsola,K., Kataja,V., Sillanpaa,P., Siivola,P., Heikinheimo,L., Eskelinen,M., Kosma,V.M., Uusitupa,M. and Hirvonen,A. (2005) XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res., 7, R987-R997.
29. Sigurdson,A.J., Hauptmann,M., Chatterjee,N., Alexander,B.H., Doody,M.M., Rutter,J.L. and Struewing,J.P. (2004) Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer, 4, 9.
30. Zhang,Y., Newcomb,P.A., Egan,K.M. et al. (2006) Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev., 15, 353-358.
31. Takanami,T., Nakamura,J., Kubota,Y. and Horiuchi,S. (2005) The Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repair ability. Mutat. Res., 582, 135-145.
32. Audebert,M., Salles,B. and Calsou,P. (2004) Involvement of poly(ADPribose) polymerase-1 and XRCC1/DNA ligase III in an alternative route for DNA double-strand breaks rejoining. J. Biol. Chem., 279, 55117-55126.
33. Wang,H., Rosidi,B., Perrault,R., Wang,M., Zhang,L., Windhofer,F. and Iliakis,G. (2005) DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Res., 65, 4020-4030.
34. Levy,N., Martz,A., Bresson,A., Spenlehauer,C., de Murcia,G. and Menissier-de Murcia,J. (2006) XRCC1 is phosphorylated by DNAdependent protein kinase in response to DNA damage. Nucleic Acids Res., 34, 32-41.
35. Hao,B., Miao,X., Li,Y. et al. (2006) A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small-cell lung cancer. Oncogene, 25, 3613-3620.